Douglas S. Ingram - 26 Jun 2021 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
President & CEO, Director
Signature
/s/ Ryan Brown, as Attorney-in-Fact for Douglas S. Ingram
Issuer symbol
SRPT
Transactions as of
26 Jun 2021
Net transactions value
-$1,432,085
Form type
4
Filing time
28 Jun 2021, 20:00:52 UTC
Previous filing
21 May 2021
Next filing
17 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Tax liability $1,432,085 -17,812 -5% $80.40 340,056 26 Jun 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Company to satisfy tax withholding obligations related to a vesting of a restricted stock award granted on June 26, 2017.